Open AccessChallenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic
Author(s) -
Chunhua Xu,
Li Li,
Wei Wang
Publication year - 2021
Publication title -
technology in cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.754
H-Index - 63
eISSN - 1533-0346
pISSN - 1533-0338
DOI - 10.1177/15330338211050764
Subject(s) - pandemic , covid-19 , lung cancer , medicine , cancer , outbreak , biopsy , intensive care medicine , lung , radiology , pathology , infectious disease (medical specialty) , disease
A pandemic of coronavirus diseases 2019 (COVID-19) outbreak is a major public health emergency that has spread in the fastest speed, and caused the most extensive infection world widely. Transbronchial biopsy (TBB) and computed tomography guided percutaneous needle biopsy (CTPNB) is the most common and significant method for the diagnosis of lung cancer. During the COVID-19 pandemic, the indications of TBB and CTPNB must be managed strictly. Therefore, it is extremely indispensable to perform meticulous and individualized management for lung cancer patients to protect the patients from COVID-19.